← Leaderboards
David C Perlman
Beth Israel Medical Ctr (New York)
$6,111,515
Attributed
$6,111,515
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $494.3K · FY2006–22$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,111,515 · 5
By mechanism
R01$3,661,853 · 2
P30$2,449,662 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug User”
- Lawrence Corey · Fred Hutchinson Cancer Center$298,997,339
- Wafaa M. El-Sadr · Columbia University Health Sciences$270,470,164
- Myron S Cohen · Family Health International$248,617,295
- Gregory D Peterson · University Of Tennessee Knoxville$100,231,290
- Deborah J Donnell · Fred Hutchinson Cancer Center$99,907,822
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$89,037,508
Research focus
Drug UserResearch PersonnelPreventionDrug UsageHiv InfectionsEpidemiologyClinical CareMedicalTransmission ProcessCommunicable DiseasesConsultationsNatural HistoryHepatitis CInfectionEpidemicTrainingCaringSocialBehavioralHealth PolicyBaseHepatitis C VirusDrug AbuseInjection Of Therapeutic Agent
Grant awards (22)
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges$255,976
P30 · FY2022 · DA · contact PI
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges$255,982
P30 · FY2021 · DA · contact PI
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges$244,267
P30 · FY2020 · DA · contact PI
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges$256,142
P30 · FY2019 · DA · contact PI
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges$271,034
P30 · FY2018 · DA · contact PI
Infectious Diseases and Biomedical Core$145,226
P30 · FY2017 · DA · contact PI
Infectious Diseases and Biomedical Core$102,568
P30 · FY2016 · DA · contact PI
Infectious Diseases and Biomedical Core$158,759
P30 · FY2014 · DA · contact PI
Infectious Diseases and Biomedical Core$116,947
P30 · FY2013 · DA · contact PI
INFECTIOUS DISEASES CORE$155,792
P30 · FY2012 · DA · contact PI
INFECTIOUS DISEASES CORE$109,028
P30 · FY2011 · DA · contact PI
Hepatitis Care Coordination in Methadone Treatment$303,315
R01 · FY2010 · DA · contact PI
INFECTIOUS DISEASES CORE$131,505
P30 · FY2010 · DA · contact PI
Hepatitis Care Coordination in Methadone Treatment$357,728
R01 · FY2009 · DA · contact PI
INFECTIOUS DISEASES CORE$136,566
P30 · FY2009 · DA · contact PI
Hepatitis Care Coordination in Methadone Treatment$354,372
R01 · FY2008 · DA · contact PI
INFECTIOUS DISEASES CORE$109,870
P30 · FY2008 · DA · contact PI
Hepatitis Care Coordination in Methadone Treatment$347,171
R01 · FY2007 · DA · contact PI
Hepatitis Care Coordination in Methadone Treatment$382,880
R01 · FY2006 · DA · contact PI
TB SCREENING AND PREVENTION IN ACTIVE USERS$469,009
R01 · FY2002 · DA
TB SCREENING AND PREVENTION IN ACTIVE USERS$730,654
R01 · FY2001 · DA
TB SCREENING AND PREVENTION IN ACTIVE USERS$716,724
R01 · FY2000 · DA